Abstract
Le et al. show that the TGF-β1-TGFβR kinase-SMAD3 pathway protects leukemia cells from PARP inhibitor (PARPi)-mediated synthetic lethality in the bone marrow microenvironment. The targeting of the TGF-β1 axis restored the sensitivity of leukemia cells to PARPi and prolonged survival of leukemia-bearing mice.
Original language | English |
---|---|
Article number | 108221 |
Journal | Cell Reports |
Volume | 33 |
Issue number | 1 |
DOIs | |
State | Published - Oct 6 2020 |
Keywords
- PARP inhibitor resistance
- TGFβR signaling
- bone marrow microenvironment
Fingerprint
Dive into the research topics of 'TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment'. Together they form a unique fingerprint.Press/Media
Equipment
-
Histopathology Facility
Cai, MD, PhD, K. (Director) & Zhang, J. (Manager)
Equipment/facility: Facility